HematologyNews.net

Hematology Xagena

Search results for "Eltrombopag"

Four studies that highlight significant advances in treatment and survival outcomes for patients with various forms of thrombocytopenia, a group of bleeding disorders characterized by a low number of ...


A double-blind, multicenter, phase III study found that long-term Eltrombopag ( Promacta, Revolade ), therapy compared with placebo treatment significantly increased platelet counts, decreased bleedin ...


Four studies that highlight significant advances in treatment and survival outcomes for patients with various forms of thrombocytopenia, a group of bleeding disorders characterized by a low number of ...


Patients suffering from a blood disorder that prevents proper clotting have the option of a new medication that may dramatically improve their health. There are estimated to be between 50,000 and 100, ...


New data from two long-term studies ( RAISE: 197 patients and EXTEND: 144 patients ) have shown that patients with idiopathic thrombocytopenic purpura ( ITP ), treated with Eltrombopag ( Revolade ), e ...


The Food and Drug Administration ( FDA ) has approved a supplemental New Drug Application ( sNDA ) for the once-daily use of Eltrombopag in patients with severe aplastic anaemia who have had an insuff ...